DAC
WST icon

Dividend Assets Capital’s West Pharmaceutical WST Stock Holding History

Dividend Assets Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31
Closed -$7K – 562
2023
Q1 		$7K Hold
31
– – ﹤0.01% 460
2022
Q4 		$7K Hold
31
– – ﹤0.01% 460
2022
Q3 		$8K Hold
31
– – ﹤0.01% 465
2022
Q2 		$9K Sell
31
-36
-54% -$11.7K ﹤0.01% 470
2022
Q1 		$28K Sell
67
-42
-39% -$16.4K 0.01% 351
2021
Q4 		$51K Buy
+109
New +$46.9K 0.01% 294

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Dividend Assets Capital's WST Position: Q2 2023 in Review

Dividend Assets Capital sold out of West Pharmaceutical (WST) in Q2 2023, closing a stake of 31 shares — an estimated $7K sold.

Dividend Assets Capital first reported a position in WST in Q4 2021 and held it in 6 quarters. The position peaked at $51K in Q4 2021. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • Dividend Assets Capital reported no remaining West Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Dividend Assets Capital sold 31 West Pharmaceutical shares in Q2 2023, an estimated $7K.
  • Dividend Assets Capital first reported a position in West Pharmaceutical in Q4 2021 and held it in 6 quarters.
  • Dividend Assets Capital's West Pharmaceutical position peaked at $51K in Q4 2021.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on Dividend Assets Capital's 13F filing for Q2 2023, filed 31 Jul 2023.